NASDAQ:ATRC

AtriCure News Headlines

$77.67
-0.04 (-0.05 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$77.01
$80.44
50-Day Range
$61.25
$77.71
52-Week Range
$34.04
$80.44
Volume246,599 shs
Average Volume406,801 shs
Market Capitalization$3.54 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.13

Headlines

AtriCure (NASDAQ ATRC) News Headlines Today

SourceHeadline
AtriCure (NASDAQ:ATRC) Lowered to "Hold" at Zacks Investment ResearchAtriCure (NASDAQ:ATRC) Lowered to "Hold" at Zacks Investment Research
marketbeat.com - April 30 at 4:40 PM
Form 4 AtriCure, Inc. For: May 05 Filed by: Lanning Mark R - StreetInsider.comForm 4 AtriCure, Inc. For: May 05 Filed by: Lanning Mark R - StreetInsider.com
streetinsider.com - May 7 at 6:41 PM
AtriCure (NASDAQ:ATRC) Hits New 12-Month High at $80.20AtriCure (NASDAQ:ATRC) Hits New 12-Month High at $80.20
americanbankingnews.com - May 7 at 12:44 PM
Form 4 AtriCure, Inc. For: May 03 Filed by: WEHRWEIN SVEN - StreetInsider.comForm 4 AtriCure, Inc. For: May 03 Filed by: WEHRWEIN SVEN - StreetInsider.com
streetinsider.com - May 5 at 2:05 PM
Insider Selling: AtriCure, Inc. (NASDAQ:ATRC) Director Sells 10,000 Shares of StockInsider Selling: AtriCure, Inc. (NASDAQ:ATRC) Director Sells 10,000 Shares of Stock
americanbankingnews.com - May 5 at 11:14 AM
AtriCure (NASDAQ:ATRC) PT Raised to $102.00AtriCure (NASDAQ:ATRC) PT Raised to $102.00
americanbankingnews.com - May 4 at 11:12 AM
AtriCure (NASDAQ:ATRC) Given New $75.00 Price Target at OppenheimerAtriCure (NASDAQ:ATRC) Given New $75.00 Price Target at Oppenheimer
americanbankingnews.com - May 4 at 10:36 AM
AtriCure (NASDAQ:ATRC) Releases FY 2021 Earnings GuidanceAtriCure (NASDAQ:ATRC) Releases FY 2021 Earnings Guidance
americanbankingnews.com - May 4 at 9:22 AM
AtriCure (NASDAQ:ATRC) Price Target Raised to $81.00 at Needham & Company LLCAtriCure (NASDAQ:ATRC) Price Target Raised to $81.00 at Needham & Company LLC
americanbankingnews.com - May 4 at 8:46 AM
AtriCure, Inc. (NASDAQ:ATRC) Expected to Post Earnings of -$0.33 Per ShareAtriCure, Inc. (NASDAQ:ATRC) Expected to Post Earnings of -$0.33 Per Share
americanbankingnews.com - May 3 at 6:46 PM
AtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock? - Yahoo FinanceAtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock? - Yahoo Finance
finance.yahoo.com - April 30 at 9:56 AM
Can You Imagine How Elated AtriCures (NASDAQ:ATRC) Shareholders Feel About Its 427% Share Price Gain?Can You Imagine How Elated AtriCure's (NASDAQ:ATRC) Shareholders Feel About Its 427% Share Price Gain?
finance.yahoo.com - April 30 at 9:56 AM
AtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock?AtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock?
finance.yahoo.com - April 30 at 9:56 AM
AtriCure Inc. (ATRC) PT Raised to $91 at Needham & Company on FDA Approval - StreetInsider.comAtriCure Inc. (ATRC) PT Raised to $91 at Needham & Company on FDA Approval - StreetInsider.com
streetinsider.com - April 29 at 7:23 PM
AtriCure (NASDAQ:ATRC) PT Raised to $85.00AtriCure (NASDAQ:ATRC) PT Raised to $85.00
americanbankingnews.com - April 29 at 6:48 PM
Stocks Showing Rising Market Leadership: Atricure Earns 81 RS Rating - Investors Business DailyStocks Showing Rising Market Leadership: Atricure Earns 81 RS Rating - Investor's Business Daily
investors.com - April 29 at 2:22 PM
AtriCures EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients - Business WireAtriCure's EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients - Business Wire
businesswire.com - April 29 at 8:13 AM
AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib PatientsAtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
finance.yahoo.com - April 29 at 8:13 AM
AtriCure (NASDAQ:ATRC) Earns Buy Rating from SVB LeerinkAtriCure (NASDAQ:ATRC) Earns Buy Rating from SVB Leerink
americanbankingnews.com - April 29 at 7:56 AM
Heres Why AtriCure Stock Is Moving Today - BenzingaHere's Why AtriCure Stock Is Moving Today - Benzinga
benzinga.com - April 28 at 11:07 PM
Heres Why AtriCure Stock Is Moving TodayHere's Why AtriCure Stock Is Moving Today
markets.businessinsider.com - April 28 at 6:06 PM
AtriCure (NASDAQ:ATRC) PT Raised to $76.00 at BTIG ResearchAtriCure (NASDAQ:ATRC) PT Raised to $76.00 at BTIG Research
americanbankingnews.com - April 28 at 3:12 PM
AtriCure Inc (ATRC) Q1 2021 Earnings Call TranscriptAtriCure Inc (ATRC) Q1 2021 Earnings Call Transcript
finance.yahoo.com - April 28 at 1:06 PM
AtriCure (NASDAQ:ATRC) PT Raised to $75.00AtriCure (NASDAQ:ATRC) PT Raised to $75.00
americanbankingnews.com - April 28 at 12:06 PM
Canaccord Genuity Reaffirms "Buy" Rating for AtriCure (NASDAQ:ATRC)Canaccord Genuity Reaffirms "Buy" Rating for AtriCure (NASDAQ:ATRC)
americanbankingnews.com - April 28 at 10:44 AM
AtriCure, Inc.s (ATRC) CEO Mike Carrel on Q1 2021 Results - Earnings Call Transcript - Seeking AlphaAtriCure, Inc.'s (ATRC) CEO Mike Carrel on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - April 28 at 8:06 AM
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo FinanceAtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - April 27 at 9:58 PM
AtriCure (NASDAQ:ATRC) Updates FY 2021 Earnings GuidanceAtriCure (NASDAQ:ATRC) Updates FY 2021 Earnings Guidance
americanbankingnews.com - April 27 at 9:26 PM
AtriCure EPS beats by $0.04, beats on revenue - Seeking AlphaAtriCure EPS beats by $0.04, beats on revenue - Seeking Alpha
seekingalpha.com - April 27 at 4:58 PM
AtriCure: Q1 Earnings Insights - BenzingaAtriCure: Q1 Earnings Insights - Benzinga
benzinga.com - April 27 at 4:58 PM
AtriCure Reports First Quarter 2021 Financial Results - Business WireAtriCure Reports First Quarter 2021 Financial Results - Business Wire
businesswire.com - April 27 at 4:58 PM
AtriCure Reports First Quarter 2021 Financial ResultsAtriCure Reports First Quarter 2021 Financial Results
finance.yahoo.com - April 27 at 4:58 PM
AtriCure (NASDAQ:ATRC)  Shares Down 3.2% AtriCure (NASDAQ:ATRC) Shares Down 3.2%
americanbankingnews.com - April 26 at 2:16 PM
Preview: AtriCures Earnings - BenzingaPreview: AtriCure's Earnings - Benzinga
benzinga.com - April 26 at 12:44 PM
AtriCure (NASDAQ:ATRC) Sets New 52-Week High at $71.16AtriCure (NASDAQ:ATRC) Sets New 52-Week High at $71.16
americanbankingnews.com - April 22 at 1:40 PM
AtriCure (NASDAQ:ATRC) & Silk Road Medical (NASDAQ:SILK) Financial AnalysisAtriCure (NASDAQ:ATRC) & Silk Road Medical (NASDAQ:SILK) Financial Analysis
americanbankingnews.com - April 19 at 2:20 AM
Head to Head Analysis: ICU Medical (NASDAQ:ICUI) versus AtriCure (NASDAQ:ATRC)Head to Head Analysis: ICU Medical (NASDAQ:ICUI) versus AtriCure (NASDAQ:ATRC)
americanbankingnews.com - April 17 at 2:40 PM
AtriCure (NASDAQ:ATRC) Hits New 1-Year High at $68.22AtriCure (NASDAQ:ATRC) Hits New 1-Year High at $68.22
americanbankingnews.com - April 17 at 7:42 AM
AtriCure Names B. Kristine Johnson Board Chair - Business WireAtriCure Names B. Kristine Johnson Board Chair - Business Wire
businesswire.com - April 8 at 12:56 PM
AtriCure Names B. Kristine Johnson Board ChairAtriCure Names B. Kristine Johnson Board Chair
finance.yahoo.com - April 8 at 12:56 PM
Have Insiders Been Buying AtriCure, Inc. (NASDAQ:ATRC) Shares This Year? - NasdaqHave Insiders Been Buying AtriCure, Inc. (NASDAQ:ATRC) Shares This Year? - Nasdaq
nasdaq.com - April 7 at 7:34 PM
AtriCure to Announce First Quarter 2021 Financial Results - Yahoo FinanceAtriCure to Announce First Quarter 2021 Financial Results - Yahoo Finance
finance.yahoo.com - April 6 at 12:15 PM
AtriCure to Announce First Quarter 2021 Financial ResultsAtriCure to Announce First Quarter 2021 Financial Results
finance.yahoo.com - April 6 at 12:15 PM
Morrisville medical company hauls in $11M to improve heart care - Triangle Business Journal - Triangle Business JournalMorrisville medical company hauls in $11M to improve heart care - Triangle Business Journal - Triangle Business Journal
bizjournals.com - March 25 at 9:21 AM
Atricure Sees Relative Strength Rating Rise To 73 - Investors Business DailyAtricure Sees Relative Strength Rating Rise To 73 - Investor's Business Daily
investors.com - March 25 at 9:21 AM
The Daily Biotech Pulse: Fulgents Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study - Yahoo FinanceThe Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study - Yahoo Finance
finance.yahoo.com - March 5 at 6:19 PM
AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference - Yahoo FinanceAtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference - Yahoo Finance
finance.yahoo.com - March 2 at 5:16 PM
AtriCure to Participate at the Oppenheimer 31st Annual Healthcare ConferenceAtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference
finance.yahoo.com - March 2 at 5:16 PM
Edited Transcript of ATRC.OQ earnings conference call or presentation 23-Feb-21 9:30pm GMT - Yahoo FinanceEdited Transcript of ATRC.OQ earnings conference call or presentation 23-Feb-21 9:30pm GMT - Yahoo Finance
finance.yahoo.com - February 24 at 3:27 PM
AtriCure Inc. (ATRC) PT Raised to $65 at Oppenheimer - StreetInsider.comAtriCure Inc. (ATRC) PT Raised to $65 at Oppenheimer - StreetInsider.com
streetinsider.com - February 24 at 9:17 AM
AtriCure Inc (ATRC) Q4 2020 Earnings Call Transcript - Motley FoolAtriCure Inc (ATRC) Q4 2020 Earnings Call Transcript - Motley Fool
fool.com - February 24 at 9:17 AM
This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.